An Exploratory RWE Study Exploring Effects of a Goat Milk Based Young Child Formula on Health Benefits
NCT ID: NCT06287385
Last Updated: 2025-08-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
121 participants
INTERVENTIONAL
2024-03-28
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study to Evaluate the Effects of a Formula on the Gut Health of Healthy Chinese Infants and Young Children
NCT04864665
Goat or Cow Milk Based Infant Formula GMS
NCT06312059
To Investigate Effects of a New Infant Formula in Healthy Term Chinese Infants
NCT03520764
Gastrointestinal Symptoms and Tolerance in Infants Fed Goat or Cow's Milk-based Infant Formula
NCT07342972
Effect Of a Goat Milk-Based Infant Formula On Gastrointestinal And Other Symptoms And Health-Related Quality Of Life.
NCT06108401
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Formula fed
Goat-milk Based Formula (Stage 3)
Goat-milk Based Formula
Provided Goat-milk Based Formula for babies 1-2 years old
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Goat-milk Based Formula
Provided Goat-milk Based Formula for babies 1-2 years old
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Healthy term infants, gestational ages 37\~42 weeks
3. Birth weight within normal range for gestational age and sex (10th to 90th percentile of the Chinese Child Growth Chart);
4. Normal weight, height at screening (10th to 90th percentile of the Chinese Child Growth Chart)
5. Chinese population;
6. Subjects whose parents/guardians are intending to goat formula feed according to protocol during the study period;
7. Informed consent from one parent or legal representative;
8. Subjects whose parents/guardians are adults, have sufficient ability in Chinese to complete informed consent and other study documents;
9. Subjects whose parents/guardians are able to use smart phone with cameras; install and use a secure WeChat platform on the mobile phone during the study period; connect to the network through the mobile phone; take photos to record stool; complete questionnaires;
10. Subjects whose parents/guardians can be directly contacted by telephone or WeChat throughout the study.
Exclusion Criteria
2. Goat-milk based formula or fresh goat milk use within 4 weeks prior to enrolment;
3. Special infant formula use within 4 weeks prior to enrolment, including but not limited to hydrolysed infant formula, lactose-free infant formula and anti-reflux infant formula etc.;
4. Known allergy to milk products or soy product;
5. Medially diagnosed disorders requiring a special diet, including but not limited to reflux esophagitis, phenylketonuria etc;
6. Significant congenital abnormality or other health conditions that could affect the outcome measurements;
7. Investigator's uncertainty about the willingness or ability of the parents to comply with the protocol requirements;
8. Participation in any other studies involving investigational or marketed products concomitantly or within 4 weeks prior to entry into the study.
1 Year
2 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Danone Nutricia
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zailing Li, PhD
Role: PRINCIPAL_INVESTIGATOR
Peking University Third Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Peking University Third Hospital
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NELN202212A
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.